SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-07-023598
Filing Date
2007-05-09
Accepted
2007-05-09 13:31:16
Documents
11
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 v073835_10q.htm 10-Q 552216
2 GRAPHIC logo_s.jpg GRAPHIC 1203
3 GRAPHIC sunesis1.jpg GRAPHIC 2905
4 v073835_ex10-48.htm EX-10.48 17310
5 GRAPHIC sunesis.jpg GRAPHIC 6702
6 v073835_ex10-49.htm EX-10.49 59054
7 v073835_ex10-50.htm EX-10.50 58490
8 v073835_ex31-1.htm EX-31.1 13560
9 v073835_ex31-2.htm EX-31.2 13758
10 v073835_ex32-1.htm EX-32.1 6239
11 v073835_ex32-2.htm EX-32.2 6021
  Complete submission text file 0001144204-07-023598.txt   743422
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 07831525
SIC: 2834 Pharmaceutical Preparations